PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.22%
Revenue growth under 50% of FSLR's 24.36%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
401.45%
Gross profit growth above 1.5x FSLR's 19.69%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
9.96%
EBIT growth below 50% of FSLR's 23.95%. Michael Burry would suspect deeper competitive or cost structure issues.
3.07%
Operating income growth under 50% of FSLR's 23.95%. Michael Burry would be concerned about deeper cost or sales issues.
19.72%
Net income growth at 50-75% of FSLR's 33.75%. Martin Whitman would question fundamental disadvantages in expenses or demand.
-40.00%
Negative EPS growth while FSLR is at 34.96%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-37.93%
Negative diluted EPS growth while FSLR is at 35.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.07%
Slight or no buybacks while FSLR is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
-0.05%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
-68.96%
Negative OCF growth while FSLR is at 48.01%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-175.51%
Negative FCF growth while FSLR is at 79.23%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
6103.75%
10Y revenue/share CAGR at 75-90% of FSLR's 6812.45%. Bill Ackman would press for new markets or product lines to narrow the gap.
6103.75%
5Y revenue/share CAGR at 75-90% of FSLR's 6812.45%. Bill Ackman would encourage strategies to match competitor’s pace.
295.54%
3Y revenue/share CAGR under 50% of FSLR's 1845.28%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
2525.30%
OCF/share CAGR of 2525.30% while FSLR is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
2525.30%
OCF/share CAGR of 2525.30% while FSLR is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
15668.27%
3Y OCF/share CAGR of 15668.27% while FSLR is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
358.17%
Below 50% of FSLR's 1806.03%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
358.17%
Below 50% of FSLR's 1806.03%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
1436.34%
3Y net income/share CAGR 1.25-1.5x FSLR's 1222.80%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
14.29%
Below 50% of FSLR's 6920.91%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
14.87%
AR growth is negative/stable vs. FSLR's 45.63%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
31.97%
We show growth while FSLR is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
7.73%
Asset growth at 50-75% of FSLR's 13.69%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
2.37%
Under 50% of FSLR's 9.57%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
12.52%
Debt growth far above FSLR's 18.49%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-126.33%
Our R&D shrinks while FSLR invests at 11.33%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-6.18%
We cut SG&A while FSLR invests at 11.17%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.